7,041 Shares in National Health Investors, Inc. $NHI Purchased by Biltmore Family Office LLC

Biltmore Family Office LLC purchased a new position in shares of National Health Investors, Inc. (NYSE:NHIFree Report) during the 4th quarter, HoldingsChannel reports. The institutional investor purchased 7,041 shares of the real estate investment trust’s stock, valued at approximately $544,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. International Assets Investment Management LLC acquired a new position in National Health Investors during the 4th quarter worth about $27,000. EverSource Wealth Advisors LLC lifted its holdings in National Health Investors by 244.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after buying an additional 288 shares in the last quarter. GAMMA Investing LLC lifted its holdings in National Health Investors by 41.8% during the 4th quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock worth $35,000 after buying an additional 136 shares in the last quarter. Key Capital Management INC bought a new stake in shares of National Health Investors during the 4th quarter valued at $47,000. Finally, Advisory Services Network LLC bought a new stake in shares of National Health Investors during the 3rd quarter valued at $65,000. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Trading Up 0.8%

National Health Investors stock opened at $74.99 on Thursday. The firm has a 50-day moving average of $81.90 and a 200-day moving average of $80.53. National Health Investors, Inc. has a one year low of $68.80 and a one year high of $91.38. The company has a debt-to-equity ratio of 0.83, a current ratio of 8.20 and a quick ratio of 8.20. The company has a market cap of $3.63 billion, a price-to-earnings ratio of 24.19, a P/E/G ratio of 4.27 and a beta of 0.55.

National Health Investors (NYSE:NHIGet Free Report) last posted its quarterly earnings data on Monday, May 4th. The real estate investment trust reported $0.82 EPS for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.39). National Health Investors had a return on equity of 9.82% and a net margin of 36.86%.The business had revenue of $115.13 million for the quarter, compared to analyst estimates of $70.22 million. During the same quarter in the prior year, the company earned $1.15 earnings per share. The company’s quarterly revenue was up 28.9% on a year-over-year basis. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, equities analysts expect that National Health Investors, Inc. will post 4.76 earnings per share for the current fiscal year.

National Health Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Tuesday, June 30th will be paid a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.9%. The ex-dividend date is Tuesday, June 30th. National Health Investors’s dividend payout ratio is currently 118.71%.

Analysts Set New Price Targets

Several analysts have commented on the stock. Truist Financial dropped their target price on shares of National Health Investors from $92.00 to $89.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. National Bank Financial set a $85.00 target price on shares of National Health Investors in a research report on Tuesday, January 20th. Cantor Fitzgerald reiterated an “overweight” rating and set a $94.00 target price on shares of National Health Investors in a report on Wednesday, April 22nd. Weiss Ratings reiterated a “buy (b)” rating on shares of National Health Investors in a report on Friday, March 27th. Finally, Wells Fargo & Company lowered their target price on National Health Investors from $86.00 to $84.00 and set an “equal weight” rating for the company in a report on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $87.50.

Check Out Our Latest Analysis on NHI

National Health Investors Company Profile

(Free Report)

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.

Recommended Stories

Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHIFree Report).

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.